All In MedTech

Device Trial Radar · NCT01672086

Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System

Last checked: Nov 20, 2026Latest source record: Oct 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

347

Actual

Start

Aug 2012

Primary completion

Jun 2016

Study completion Jun 2016

Sponsor

Lead sponsor
StelKast, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 24, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The active surveillance post-approval study of the Stelkast Surpass Acetabular System is a retrospective, multi-center, single-arm study intended to collect data on the survivorship and long-term safety and effectiveness of the device.

Conditions

  • Survivorship and Long-term Safety and Effectiveness of the Stelkast Surpass Acetabular System

Interventions

  • Stelkast Surpass Acetabular System implantDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SurvivorshipTime frame: 10 Years

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Gill Orthopedic Clinic

    Charlotte, North Carolina

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.